LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 10 of 15: Cell count and normalized growth rate inhibition values within biological replicate 3. - Dataset - HMS LINCS Database

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 10 of 15: Cell count and normalized growth rate inhibition values within biological replicate 3. - Dataset (ID:20247)

Download: Excel (XLSX), Comma-separated (CSV)

<<<<

Select the entities to show:

Small molecules	Cells

|<
<<
Previous
Page 346 of 535
Next
>>
>
8626 to 8650 of 13356 records
per page:

Cell	Small Molecule	Small Mol Concentration	Small Mol Conc Unit	LJP Library Plate	Replicate	Assay Well	Timepoint	Timepoint Unit	Total Cell Count Before Treatment	Total Cell Count After Treatment	Total Control Cell Count	Relative Cell Count	Normalized Growth Rate Inhibition Value
BT-20	GDC-0980	0.12	uM	LJP5	1	K23	72	hr	1097	976	3735	0.2613	-0.0641
BT-20	GDC-0980	0.12	uM	LJP5	2	K23	72	hr	1097	973	3877	0.2509	-0.0639
BT-20	GDC-0980	0.12	uM	LJP5	3	K23	72	hr	1097	1004	3925	0.2558	-0.0472
BT-20	GDC-0980	0.37	uM	LJP5	1	K22	72	hr	1097	891	3735	0.2385	-0.1111
BT-20	GDC-0980	0.37	uM	LJP5	2	K22	72	hr	1097	859	3877	0.2215	-0.1258
BT-20	GDC-0980	0.37	uM	LJP5	3	K22	72	hr	1097	856	3925	0.2181	-0.1263
BT-20	GDC-0980	1.11	uM	LJP5	1	K21	72	hr	1097	805	3735	0.2155	-0.1608
BT-20	GDC-0980	1.11	uM	LJP5	2	K21	72	hr	1097	851	3877	0.2195	-0.1302
BT-20	GDC-0980	1.11	uM	LJP5	3	K21	72	hr	1097	840	3925	0.2140	-0.1352
BT-20	GDC-0980	3.33	uM	LJP5	1	K20	72	hr	1097	762	3735	0.2040	-0.1864
BT-20	GDC-0980	3.33	uM	LJP5	2	K20	72	hr	1097	853	3877	0.2200	-0.1291
BT-20	GDC-0980	3.33	uM	LJP5	3	K20	72	hr	1097	742	3925	0.1890	-0.1916
BT-20	GDC-0980	10	uM	LJP5	1	K19	72	hr	1097	741	3735	0.1984	-0.1992
BT-20	GDC-0980	10	uM	LJP5	2	K19	72	hr	1097	805	3877	0.2076	-0.1564
BT-20	GDC-0980	10	uM	LJP5	3	K19	72	hr	1097	717	3925	0.1827	-0.2066
BT-20	Mitoxantrone	0.04	uM	LJP6	1	C24	72	hr	1097	1587	3610	0.4395	0.2396
BT-20	Mitoxantrone	0.04	uM	LJP6	2	C24	72	hr	1097	1243	3713	0.3347	0.0735
BT-20	Mitoxantrone	0.04	uM	LJP6	3	C24	72	hr	1097	1382	3696	0.3739	0.1407
BT-20	Mitoxantrone	0.04	uM	LJP5	1	C24	72	hr	1097	1374	3735	0.3679	0.1357
BT-20	Mitoxantrone	0.04	uM	LJP5	2	C24	72	hr	1097	1438	3877	0.3708	0.1601
BT-20	Mitoxantrone	0.04	uM	LJP5	3	C24	72	hr	1097	1567	3925	0.3992	0.2138
BT-20	Mitoxantrone	0.12	uM	LJP6	1	C23	72	hr	1097	1172	3610	0.3246	0.0391
BT-20	Mitoxantrone	0.12	uM	LJP6	2	C23	72	hr	1097	1146	3713	0.3086	0.0250
BT-20	Mitoxantrone	0.12	uM	LJP6	3	C23	72	hr	1097	1131	3696	0.3060	0.0174
BT-20	Mitoxantrone	0.12	uM	LJP5	1	C23	72	hr	1097	1026	3735	0.2747	-0.0373

|<
<<
Previous
Page 346 of 535
Next
>>
>
8626 to 8650 of 13356 records
per page:

HMS LINCS Project

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 10 of 15: Cell count and normalized growth rate inhibition values within biological replicate 3. - Dataset (ID:20247)